Valuation Stratec SE Deutsche Boerse AG
Stocks
SBS
DE000STRA555
Advanced Medical Equipment & Technology
|
Real-time Estimate
Tradegate
05:30:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 21.85 EUR | +0.69% |
|
-3.59% | -2.93% |
| 08-18 | Stratec SE : Deutsche Bank is Neutral | ZD |
| 08-17 | Stratec SE : Deutsche Bank reiterates its Neutral rating | ZD |
Company Valuation: Stratec SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,669 | 983.7 | 553.7 | 362.2 | 272.9 | 267.4 | - | - |
| Change | - | -41.06% | -43.71% | -34.58% | -24.66% | -2% | - | - |
| Enterprise Value (EV) 1 | 1,705 | 983.7 | 520.2 | 451.5 | 385.4 | 359.7 | 363.6 | 361.6 |
| Change | - | -42.32% | -47.12% | -13.2% | -14.65% | -6.67% | 1.1% | -0.56% |
| P/E | 42x | 33.8x | 42.6x | 22.6x | -1,123x | 20.3x | 14.6x | 12.9x |
| PBR | 8.12x | - | 2.37x | 1.49x | 1.15x | 1.1x | 1.07x | 1.02x |
| PEG | - | -1.3x | -0.8x | 1x | 11x | -0x | 0.4x | 1x |
| Capitalization / Revenue | 5.81x | 3.58x | 2.11x | 1.41x | 1.09x | 1.02x | 0.94x | 0.9x |
| EV / Revenue | 5.94x | 3.58x | 1.99x | 1.75x | 1.54x | 1.37x | 1.28x | 1.22x |
| EV / EBITDA | 25.6x | 16.8x | 12.5x | 9.17x | 9.48x | 8.95x | 7.58x | 6.96x |
| EV / EBIT | 31.4x | 21.8x | 19.2x | 13.5x | 15.3x | 15.5x | 12.2x | 10.4x |
| EV / FCF | 39.4x | - | 46.9x | 11.6x | -23.1x | 10.6x | 19.5x | 22.7x |
| FCF Yield | 2.54% | - | 2.13% | 8.6% | -4.32% | 9.43% | 5.12% | 4.4% |
| Dividend per Share 2 | 0.952 | - | 0.55 | 0.6 | 0.6 | 0.6364 | 0.7711 | 0.8574 |
| Rate of return | 0.69% | - | 1.21% | 2.01% | 2.67% | 2.89% | 3.5% | 3.9% |
| EPS 2 | 3.28 | 2.4 | 1.07 | 1.32 | -0.02 | 1.084 | 1.505 | 1.705 |
| Distribution rate | 29% | - | 51.4% | 45.5% | -3,000% | 58.7% | 51.2% | 50.3% |
| Net sales 1 | 287.3 | 274.6 | 261.9 | 257.6 | 250.9 | 261.9 | 283.3 | 297 |
| EBITDA 1 | 66.61 | 58.58 | 41.58 | 49.21 | 40.64 | 40.18 | 48 | 51.96 |
| EBIT 1 | 54.27 | 45.05 | 27.07 | 33.46 | 25.17 | 23.2 | 29.81 | 34.78 |
| Net income 1 | 39.96 | 29.22 | 13.07 | 16.02 | -0.242 | 13.21 | 18.23 | 19.99 |
| Net Debt 1 | 36.57 | - | -33.53 | 89.25 | 112.5 | 92.22 | 96.19 | 94.15 |
| Reference price 2 | 137.80 | 81.10 | 45.55 | 29.80 | 22.45 | 22.00 | 22.00 | 22.00 |
| Nbr of stocks (in thousands) | 12,111 | 12,130 | 12,156 | 12,156 | 12,156 | 12,156 | - | - |
| Announcement Date | 3/30/22 | 3/28/23 | 3/28/24 | 5/19/25 | 4/28/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.55x | 5.86x | 22.46x | 0.27% | 250B | |
| 37.53x | 6.7x | 21.23x | 0.64% | 156B | |
| 44.07x | 11.66x | 25.74x | -.--% | 144B | |
| 16.51x | 3.39x | 11.05x | -.--% | 63.26B | |
| 34.11x | 6.82x | 21.58x | -.--% | 49.75B | |
| 33.56x | 6.64x | 22.54x | 0.6% | 48.58B | |
| 18.65x | 2.28x | 11.55x | 2.7% | 47.99B | |
| 43.7x | 10.61x | 23.39x | -.--% | 46.22B | |
| 76.92x | 7.32x | 22.3x | -.--% | 43.17B | |
| Average | 37.62x | 6.81x | 20.20x | 0.47% | 94.22B | |
| Weighted average by Cap. | 36.74x | 7.04x | 21.32x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SBS Stock
- SBS Stock
- Valuation Stratec SE
Select your edition
All financial news and data tailored to specific country editions
